APA

Peter B., Winter G. E., Blatt K., Bennett K. L., Stefanzl G., Rix U., Eisenwort G., Hadzijusufovic E., Gridling M., Dutreix C., Hoermann G., Schwaab J., Radia D., Roesel J., Manley P. W., Reiter A., Superti-Furga G. & Valent P. (20160722). Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth. : Leukemia.

Chicago

Peter B, Winter G E, Blatt K, Bennett K L, Stefanzl G, Rix U, Eisenwort G, Hadzijusufovic E, Gridling M, Dutreix C, Hoermann G, Schwaab J, Radia D, Roesel J, Manley P W, Reiter A, Superti-Furga G and Valent P. 20160722. Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth. : Leukemia.

Harvard

Peter B., Winter G. E., Blatt K., Bennett K. L., Stefanzl G., Rix U., Eisenwort G., Hadzijusufovic E., Gridling M., Dutreix C., Hoermann G., Schwaab J., Radia D., Roesel J., Manley P. W., Reiter A., Superti-Furga G. and Valent P. (20160722). Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth. : Leukemia.

MLA

Peter B, Winter G E, Blatt K, Bennett K L, Stefanzl G, Rix U, Eisenwort G, Hadzijusufovic E, Gridling M, Dutreix C, Hoermann G, Schwaab J, Radia D, Roesel J, Manley P W, Reiter A, Superti-Furga G and Valent P. Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth. : Leukemia. 20160722.